Nuvalent Inc (NASDAQ: NUVL) is -14.77% lower on its value in year-to-date trading and has touched a low of $55.53 and a high of $113.51 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NUVL stock was last observed hovering at around $68.19 in the last trading session, with the day’s loss setting it -1.47%.
Currently trading at $66.72, the stock is -6.60% and -7.41% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.14 million and changing -2.16% at the moment leaves the stock -20.22% off its SMA200. NUVL registered -5.16% loss for a year compared to 6-month loss of -25.22%.
The stock witnessed a 3.15% gain in the last 1 month and extending the period to 3 months gives it a -25.00%, and is -13.07% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.29% over the week and 6.43% over the month.
Nuvalent Inc (NUVL) has around 142 employees, a market worth around $4.79B and $0.00M in sales. Distance from 52-week low is 20.14% and -41.22% from its 52-week high. The company has generated returns on investments over the last 12 months (-24.37%).
The EPS is expected to shrink by -18.22% this year
The shares outstanding are 65.91M, and float is at 44.48M with Short Float at 14.56%.
The top institutional shareholder in the company is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with over 19.99 million shares valued at $1.52 billion. The investor’s holdings represent 30.9433 of the NUVL Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 8.87 million shares valued at $672.73 million to account for 13.7266 of the shares outstanding. The other top investors are PARADIGM BIOCAPITAL ADVISORS LP which holds 4.57 million shares representing 7.0763 and valued at over $346.81 million, while VANGUARD GROUP INC holds 5.8447 of the shares totaling 3.78 million with a market value of $286.45 million.
Nuvalent Inc (NUVL) Insider Activity
The most recent transaction is an insider sale by Noci Darlene, the company’s Chief Development Officer. SEC filings show that Noci Darlene sold 4,000 shares of the company’s common stock on Apr 29 ’25 at a price of $74.56 per share for a total of $0.3 million. Following the sale, the insider now owns 48034.0 shares.
Nuvalent Inc disclosed in a document filed with the SEC on Apr 15 ’25 that Porter James Richard (President and CEO) sold a total of 27,000 shares of the company’s common stock. The trade occurred on Apr 15 ’25 and was made at $68.94 per share for $1.86 million. Following the transaction, the insider now directly holds 0.25 million shares of the NUVL stock.
Still, SEC filings show that on Apr 15 ’25, James Richard Porter (Officer) Proposed Sale 81,000 shares at an average price of $70.00 for $5.67 million. The insider now directly holds shares of Nuvalent Inc (NUVL).
